10:43 AM EDT, 03/14/2024 (MT Newswires) -- Y-mAbs Therapeutics ( YMAB ) said Thursday that Chief Financial Officer Bo Kruse plans to resign, but will remain in that role until his successor is appointed.

Kruse will continue as a non-executive employee from the time the new CFO joins the company through July 31, Y-mAbs said, adding that a search process for a new CFO is underway.

The company's shares were down 6% in recent trading.

Price: 14.89, Change: -0.95, Percent Change: -6.00